Document is current
Any future updates will be listed below
-
Authors
Riesenberg, Stephan https://orcid.org/0000-0001-8171-1717
Kanis, Philipp https://orcid.org/0000-0003-4705-4447
Karlic, Rosa https://orcid.org/0000-0002-1291-2897
Maricic, Tomislav https://orcid.org/0000-0003-3267-0474
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
NOMIS Stiftung
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 8 May 2025
First Online: 21 May 2025
Competing interests
: Related patent applications on DNA-PKcs inhibitors for increasing genome editing efficiency (patent applicant: Max Planck Society; inventors: S.R. and T.M.; application number: EP18215071.4) and GOLD-gRNA (patent applicant: Max Planck Society, inventors: S.R., N.H., and T.M. application number: EP21176366.9) have been filed. The remaining authors declare no competing interests.
